Apotex recalls hypertension capsules that may be empty; Tobacco gets bioengineered;

> Apotex, is voluntarily recalling Lot JR2178 of hypertension drug Apo-Ramipril 5-mg capsules because some of the capsules are empty. Story

> Inserogen, a startup formed by a Ph.D. from the Universtiy of California-Davis, intends to use its "SwiftVax" plants to turn tobacco into cheap biological factories for bioengineered proteins. Story

> A survey of U.S. and EU pharmaceutical executives found a significant number who believe that "the business model is broken" and needs to be addressed by redeploying resources. Release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.